F-18-Flumazenil: A gamma-Aminobutyric Acid A-Specific PET Radiotracer for the Localization of Drug-Resistant Temporal Lobe Epilepsy
Lucy Vivash, Marie-Claude Gregoire, Eddie W Lau, Robert E Ware, David Binns, Peter Roselt, Viviane Bouilleret, Damian E Myers, Mark J Cook, Rodney J Hicks, Terence J O'Brien
Journal of Nuclear Medicine | SOC NUCLEAR MEDICINE INC | Published : 2013
The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. This study was funded by the Cooperative Research Centre for Biomedical Imaging Development Ltd. (CRCBID), Bundoora, Victoria, Australia, established and supported under the Australian Government's Cooperative Research Centers program. Core academic partners of the CRC for Biomedical Imaging Development are the Australian Nuclear Science and Technology Organization (ANSTO), Menai, NSW; the Garvan Institute of Medical Research, Darlinghurst, NSW; Monash University, Clayton, VIC; and the Peter MacCallum Cancer Centre, Melbourne, VIC, all in Australia. Core commercial partners are Berthold Australia Pty Ltd., Bundoora, VIC; Cyclotek (Aust) Pty Ltd., Bundoora, VIC, Australia; and GE Healthcare Pty Ltd., Rydalmere, NSW, Australia. No other potential conflict of interest relevant to this article was reported.